Humanwell Healthcare (Group) Co (SHSE:600079) Cyclically Adjusted FCF per Share: ¥0.13 (As of Mar. 2026)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

SHSE:600079 Humanwell Healthcare (Group) Co Ltd SHSE:600079
58 GF Score
Price ¥17.69
GF Value ¥21.71
Valuation Modestly Undervalued
! 2 Warning Signs
View Full Analysis

What is Humanwell Healthcare (Group) Co Cyclically Adjusted FCF per Share?

Humanwell Healthcare (Group) Co SHSE:600079 +1.38% 58 Cyclically Adjusted FCF per Share is ¥0.13 as of Mar. 2026. GuruFocus rates SHSE:600079 with a GF Score™ of 58/100 and a GF Value™ of ¥21.71 (Modestly Undervalued). The stock has 2 warning signs investors should review.

E10 is a concept invented by Prof. Robert Shiller, who uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted FCF per Share and the Cyclically Adjusted Price-to-FCF. The Cyclically Adjusted FCF per Share is the average of the inflation adjusted Free Cash Flow per Share of a company over the past 10 years.

Humanwell Healthcare (Group) Co's adjusted free cash flow per share for the three months ended in Mar. 2026 was ¥0.115. Add all the adjusted free cash flow per share for the past 10 years together and divide the count will get our Cyclically Adjusted FCF per Share, which is ¥0.13 for the trailing ten years ended in Mar. 2026.

Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the Cyclically Adjusted FCF Growth Rate using Cyclically Adjusted FCF per Share data.

During the past 13 years, the highest 3-Year average Cyclically Adjusted FCF Growth Rate of Humanwell Healthcare (Group) Co was 37.90% per year. The lowest was -152.00% per year. And the median was -16.95% per year.

As of today (2026-07-19), Humanwell Healthcare (Group) Co's current stock price is ¥17.69. Humanwell Healthcare (Group) Co's Cyclically Adjusted FCF per Share for the quarter that ended in Mar. 2026 was ¥0.13. Humanwell Healthcare (Group) Co's Cyclically Adjusted Price-to-FCF of today is 136.08.

During the past 13 years, the highest Cyclically Adjusted Price-to-FCF of Humanwell Healthcare (Group) Co was 2215.00. The lowest was 125.92. And the median was 197.10.


Humanwell Healthcare (Group) Co  (SHSE:600079) Cyclically Adjusted FCF per Share Explanation

If a company grows much fast than inflation, Cyclically Adjusted FCF per Share may underestimate the company's free cash flow. Cyclically Adjusted Price-to-FCF can seem to be too high even the actual Price-to-Free-Cash-Flow is low.

For the Cyclically Adjusted Price-to-FCF, the free cash flow per share of the past 10 years are inflation-adjusted and averaged. The result is used for P/FCF calculation. Since it looks at the average over the last 10 years, the Cyclically Adjusted Price-to-FCF is also called CAPFCF Ratio.

The Shiller PE Ratio was first used by professor Robert Shiller. He uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings per share of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted Price-to-FCF. The Cyclically Adjusted FCF per Share is the average of the inflation adjusted free cash flow per share of a company over the past 10 years.

Humanwell Healthcare (Group) Co's Cyclically Adjusted Price-to-FCF of today is calculated as

Cyclically Adjusted Price-to-FCF=Share Price/Cyclically Adjusted FCF per Share
=17.69/0.13
=136.08

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

During the past 13 years, the highest Cyclically Adjusted Price-to-FCF of Humanwell Healthcare (Group) Co was 2215.00. The lowest was 125.92. And the median was 197.10.


Be Aware

Cyclically Adjusted Price-to-FCF works better for cyclical companies. It gives you a better idea on the company's real free cash flow value.


Humanwell Healthcare (Group) Co Cyclically Adjusted FCF per Share Related Terms


Humanwell Healthcare (Group) Co Cyclically Adjusted FCF per Share Historical Data

* Premium members only.

The historical data trend for Humanwell Healthcare (Group) Co's Cyclically Adjusted FCF per Share can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Humanwell Healthcare (Group) Co Cyclically Adjusted FCF per Share Chart

Humanwell Healthcare (Group) Co Annual Data
Trend Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
Cyclically Adjusted FCF per Share
Get a 7-Day Free Trial Premium Member Only Premium Member Only -0.25 -0.22 -0.17 -0.06 0.10

Humanwell Healthcare (Group) Co Quarterly Data
Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26
Cyclically Adjusted FCF per Share Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only -0.08 0.01 0.06 0.10 0.13

SHSE:600079 vs ZTS, UTHR: Cyclically Adjusted FCF per Share Comparison

For the Drug Manufacturers - Specialty & Generic subindustry, Humanwell Healthcare (Group) Co's Cyclically Adjusted Price-to-FCF, along with its competitors' market caps and Cyclically Adjusted Price-to-FCF data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Humanwell Healthcare (Group) Co Cyclically Adjusted Price-to-FCF vs Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Humanwell Healthcare (Group) Co's Cyclically Adjusted Price-to-FCF distribution charts can be found below:

* The bar in red indicates where Humanwell Healthcare (Group) Co's Cyclically Adjusted Price-to-FCF falls into.


SHSE:600079
58GF Score
Humanwell Healthcare (Group) Co Ltd SHSE:600079
Cyclically Adjusted FCF per Share is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Humanwell Healthcare (Group) Co Cyclically Adjusted FCF per Share Calculation

E10 is a concept invented by Prof. Robert Shiller, who uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted FCF per Share and the Cyclically Adjusted Price-to-FCF. The Cyclically Adjusted FCF per Share is the average of the inflation adjusted Free Cash Flow per Share of a company over the past 10 years.

What is Cyclically Adjusted FCF per Share? How do we calculate Cyclically Adjusted FCF per Share?

Cyclically Adjusted FCF per Share is the average of the inflation adjusted Free Cash Flow per Share of a company over the past 10 years. Let's use an example to explain.

If we want to calculate the Cyclically Adjusted FCF per Share of Wal-Mart (WMT) for Dec. 31, 2010, we need to have the inflation data and the free cash flow per share from 2001 through 2010.

We adjusted the 2001 free cash flow per share data with the total inflation from 2001 through 2010 to the equivalent free cash flow in 2010. If the total inflation from 2001 to 2010 is 40%, and Wal-Mart's free cash flow is $1 a share in 2001, then the 2001's equivalent free cash flow in 2010 is $1.4 a share. If Wal-Mart's free cash flow is $1 again in 2002, and the total inflation from 2002 through 2010 is 35%, then the equivalent 2002 free cash flow in 2010 is $1.35. So on and so forth, you get the equivalent free cash flow per share of past 10 years. Then you add them together and divided the sum by the count to get Cyclically Adjusted FCF per Share.

Please note that we use the CPI data of the country/region where the company is headquartered. If the CPI data for that country/region is not available, then we will use the CPI data of the United States as default.

For example, Humanwell Healthcare (Group) Co's adjusted Free Cash Flow per Share data for the three months ended in Mar. 2026 was:

Adj_FreeCashFlowPerShare= Free Cash Flow per Share /CPI of Mar. 2026 (Change)*Current CPI (Mar. 2026)
=0.115/116.3033*116.3033
=0.115

Current CPI (Mar. 2026) = 116.3033.

Humanwell Healthcare (Group) Co Quarterly Data

Free Cash Flow per Share CPI Adj_FreeCashFlowPerShare
201606 -0.001 101.400 -0.001
201609 -0.138 102.400 -0.157
201612 -0.244 102.600 -0.277
201703 -0.558 103.200 -0.629
201706 -0.140 103.100 -0.158
201709 -0.189 104.100 -0.211
201712 -0.281 104.500 -0.313
201803 -0.518 105.300 -0.572
201806 -0.117 104.900 -0.130
201809 -0.196 106.600 -0.214
201812 0.458 106.500 0.500
201903 -0.139 107.700 -0.150
201906 0.119 107.700 0.129
201909 0.284 109.800 0.301
201912 0.609 111.200 0.637
202003 -0.211 112.300 -0.219
202006 0.028 110.400 0.029
202009 0.371 111.700 0.386
202012 0.513 111.500 0.535
202103 -0.314 112.662 -0.324
202106 0.068 111.769 0.071
202109 0.039 112.215 0.040
202112 0.501 113.108 0.515
202203 -1.186 114.335 -1.206
202206 0.007 114.558 0.007
202209 0.096 115.339 0.097
202212 0.680 115.116 0.687
202303 -0.567 115.116 -0.573
202306 0.260 114.558 0.264
202309 0.005 115.339 0.005
202312 0.299 114.781 0.303
202403 -0.309 115.227 -0.312
202406 0.491 114.781 0.498
202409 0.237 115.785 0.238
202412 0.275 114.893 0.278
202503 -0.358 115.116 -0.362
202506 0.658 114.907 0.666
202509 0.325 115.471 0.327
202512 0.481 115.832 0.483
202603 0.115 116.303 0.115

Add all the adjusted free cash flow per share together and divide 10 will get our Cyclically Adjusted FCF per Share.

What does a Cyclically Adjusted FCF per Share of ¥0.13 mean?
Humanwell Healthcare (Group) Co (SHSE:600079) has a Cyclically Adjusted FCF per Share of ¥0.13 as of Mar. 2026. Cyclically Adjusted FCF per Share represents the company's inflation-adjusted FCF per share over a 10-year period. View historical data on Humanwell Healthcare (Group) Co and its competitors.
Is Humanwell Healthcare (Group) Co's Cyclically Adjusted FCF per Share too high?
Humanwell Healthcare (Group) Co's current Cyclically Adjusted FCF per Share is ¥0.13. Overall, Humanwell Healthcare (Group) Co has a GF Score™ of 58/100 and is considered Modestly Undervalued, reflecting its overall financial health beyond just this single metric.
How does Humanwell Healthcare (Group) Co's Cyclically Adjusted FCF per Share compare to ZTS and UTHR?
Humanwell Healthcare (Group) Co's Cyclically Adjusted FCF per Share of ¥0.13 can be compared against companies in the Drug Manufacturers industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Cyclically Adjusted FCF per Share for a Drug Manufacturers company?
A good Cyclically Adjusted FCF per Share depends on the Drug Manufacturers industry context. However, Cyclically Adjusted FCF per Share should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Cyclically Adjusted FCF per Share mean?
A high Cyclically Adjusted FCF per Share can signal that a stock is expensive relative to its fundamentals. Cyclically Adjusted FCF per Share represents the company's inflation-adjusted FCF per share over a 10-year period. View historical data on Humanwell Healthcare (Group) Co and its competitors. Humanwell Healthcare (Group) Co's current Cyclically Adjusted FCF per Share is ¥0.13. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Humanwell Healthcare (Group) Co stock overvalued right now?
Based on GuruFocus' analysis, Humanwell Healthcare (Group) Co (SHSE:600079) is currently considered Modestly Undervalued. The stock's GF Value™ is ¥21.71, compared to a current price of ¥17.69 — trading 18.5% below its estimated fair value. The current Cyclically Adjusted FCF per Share is ¥0.13. Humanwell Healthcare (Group) Co's overall GF Score™ is 58/100 with 2 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Cyclically Adjusted FCF per Share calculated?
Cyclically Adjusted FCF per Share is calculated from a company's financial statements. For Humanwell Healthcare (Group) Co (SHSE:600079), the current Cyclically Adjusted FCF per Share is ¥0.13 as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Humanwell Healthcare (Group) Co (SHSE:600079) Overvalued in 2026?

Based on GuruFocus' analysis, Humanwell Healthcare (Group) Co stock appears to be undervalued. The current stock price of ¥17.69 is trading 18.5% below its estimated GF Value™ of ¥21.71. GuruFocus considers Humanwell Healthcare (Group) Co to be Modestly Undervalued.

Key valuation signals for SHSE:600079:

  • Cyclically Adjusted FCF per Share: ¥0.13
  • GF Value™: ¥21.71 vs. price of ¥17.69 (18.5% below fair value)
  • GF Score™: 58/100 with 2 warning signs

No single metric tells the full story. See the SHSE:600079 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.


Humanwell Healthcare (Group) Co Business Description

Address No. 666, Gaoxin Avenue, East Lake High-tech Development Zone, Hubei Province, Wuhan, CHN, 430075
Humanwell Healthcare (Group) Co Ltd is a China-based integrated healthcare solution provider. It provides medicinal products including fertility-regulating drugs, Uyghur medicine, traditional Chinese medicine, medical devices, over-the-counter medicines, anti-infection drugs, herbal medicines, and biological products. The organization has a business presence in China and other international countries.
58GF Score

Get the complete analysis for SHSE:600079

Cyclically Adjusted FCF per Share is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

¥17.69
Price
¥21.71
GF Value